GHK-Cu is explored for its ability to support tissue repair pathways through cellular signaling and growth factor modulation
Recalls & Warnings September 13, 2013 Metagenics Warned For Misbranding of Medical Foods and Drug Claims On August 13, 2013, the FDA issued a warning letter to Metagenics, Inc
#Bioengineering #Organogenesis #MedicalResearch #SyntheticBiology To view or add a comment, sign in From MBoC: Arthur Beyder, Mayo Clinic, explores how sensory enteroendocrine cells integrate calcium and cAMP signaling to translate gut stimuli into hormonal and neural responses
Timestamps 0:00 A 43-year-old man is getting weaker, not stronger 2:09 Taking the history: Medications, lifestyle, and red flags 12:53 The labs come back: CK at 18,979 16:05 Metabolic syndrome and the modern treatment approach 23:15 Rhabdomyolysis: What it is and why its dangerous 29:50 Final diagnosis and what went wrong with the medications 37:15 2026 ACC lipid guidelines: What changed 40:32 Three mechanisms: How statins affect muscle 47:02 The nocebo effect and the SAMSON trial 54:17 Do statins impair training